Green Cross Holdings Corporation (005250.KS)
KRW 13740.0
(1.4%)
KRW 13740.0
(1.4%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 603.58 Billion KRW | -19.28% |
| 2022 | 698.33 Billion KRW | 11.1% |
| 2021 | 628.54 Billion KRW | 18.53% |
| 2020 | 530.29 Billion KRW | 23.38% |
| 2019 | 429.78 Billion KRW | 5.91% |
| 2018 | 405.81 Billion KRW | -1.42% |
| 2017 | 411.67 Billion KRW | 4.97% |
| 2016 | 392.19 Billion KRW | 6.33% |
| 2015 | 368.84 Billion KRW | 9.65% |
| 2014 | 336.39 Billion KRW | 13.89% |
| 2013 | 295.35 Billion KRW | 8.01% |
| 2012 | 273.46 Billion KRW | -3.28% |
| 2011 | 282.75 Billion KRW | -15.15% |
| 2010 | 333.23 Billion KRW | 17.06% |
| 2009 | 284.68 Billion KRW | 29.73% |
| 2008 | 219.43 Billion KRW | -16.91% |
| 2007 | 264.09 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 156.71 Billion KRW | 51.28% |
| 2024 Q1 | 111.57 Billion KRW | -11.16% |
| 2023 Q1 | 124.11 Billion KRW | -18.92% |
| 2023 Q3 | 170.96 Billion KRW | 1.88% |
| 2023 Q2 | 167.8 Billion KRW | 35.2% |
| 2023 Q4 | 125.58 Billion KRW | -26.54% |
| 2023 FY | 563.69 Billion KRW | -19.28% |
| 2022 Q2 | 172.16 Billion KRW | -2.97% |
| 2022 Q3 | 195.66 Billion KRW | 13.65% |
| 2022 Q4 | 153.07 Billion KRW | -21.76% |
| 2022 Q1 | 177.43 Billion KRW | 17.18% |
| 2022 FY | 698.33 Billion KRW | 11.1% |
| 2021 Q1 | 120.73 Billion KRW | -13.74% |
| 2021 Q4 | 151.42 Billion KRW | -28.45% |
| 2021 FY | 628.54 Billion KRW | 18.53% |
| 2021 Q3 | 211.64 Billion KRW | 46.23% |
| 2021 Q2 | 144.73 Billion KRW | 19.88% |
| 2020 Q2 | 124.59 Billion KRW | 18.44% |
| 2020 Q1 | 105.19 Billion KRW | 6.49% |
| 2020 Q3 | 160.74 Billion KRW | 29.01% |
| 2020 FY | 530.29 Billion KRW | 23.38% |
| 2020 Q4 | 139.95 Billion KRW | -12.93% |
| 2019 Q2 | 110.5 Billion KRW | 26.01% |
| 2019 Q4 | 98.78 Billion KRW | -24.92% |
| 2019 FY | 429.78 Billion KRW | 5.91% |
| 2019 Q3 | 131.58 Billion KRW | 19.08% |
| 2019 Q1 | 87.69 Billion KRW | -6.34% |
| 2018 Q2 | 100.64 Billion KRW | 6.43% |
| 2018 Q3 | 116.97 Billion KRW | 16.23% |
| 2018 FY | 405.81 Billion KRW | -1.42% |
| 2018 Q1 | 94.56 Billion KRW | 6.17% |
| 2018 Q4 | 93.62 Billion KRW | -19.96% |
| 2017 FY | 411.67 Billion KRW | 4.97% |
| 2017 Q4 | 89.06 Billion KRW | -28.61% |
| 2017 Q3 | 124.75 Billion KRW | 10.54% |
| 2017 Q2 | 112.86 Billion KRW | 32.79% |
| 2017 Q1 | 84.99 Billion KRW | -19.31% |
| 2016 Q1 | 76.76 Billion KRW | -12.4% |
| 2016 Q2 | 100.12 Billion KRW | 30.44% |
| 2016 Q3 | 109.98 Billion KRW | 9.84% |
| 2016 Q4 | 105.32 Billion KRW | -4.24% |
| 2016 FY | 392.19 Billion KRW | 6.33% |
| 2015 FY | 368.84 Billion KRW | 9.65% |
| 2015 Q4 | 87.62 Billion KRW | -22.87% |
| 2015 Q3 | 113.61 Billion KRW | 17.55% |
| 2015 Q2 | 96.65 Billion KRW | 36.2% |
| 2015 Q1 | 70.96 Billion KRW | -10.75% |
| 2014 FY | 336.39 Billion KRW | 13.89% |
| 2014 Q3 | 108.38 Billion KRW | 42.01% |
| 2014 Q2 | 76.32 Billion KRW | 5.75% |
| 2014 Q1 | 72.17 Billion KRW | 5.19% |
| 2014 Q4 | 79.5 Billion KRW | -26.64% |
| 2013 Q4 | 68.61 Billion KRW | -30.32% |
| 2013 FY | 295.35 Billion KRW | 8.01% |
| 2013 Q1 | 60.85 Billion KRW | 5.5% |
| 2013 Q2 | 67.41 Billion KRW | 10.77% |
| 2013 Q3 | 98.47 Billion KRW | 46.07% |
| 2012 Q3 | 90.56 Billion KRW | 46.46% |
| 2012 Q2 | 61.83 Billion KRW | -2.44% |
| 2012 Q1 | 63.38 Billion KRW | -0.39% |
| 2012 FY | 273.46 Billion KRW | -3.28% |
| 2012 Q4 | 57.68 Billion KRW | -36.31% |
| 2011 Q1 | 58.86 Billion KRW | 0.0% |
| 2011 Q3 | 92.09 Billion KRW | 45.31% |
| 2011 Q4 | 63.62 Billion KRW | -30.91% |
| 2011 Q2 | 63.37 Billion KRW | 7.67% |
| 2011 FY | 282.75 Billion KRW | -15.15% |
| 2010 Q2 | 4.93 Billion KRW | -35.06% |
| 2010 Q3 | 5.91 Billion KRW | 19.82% |
| 2010 FY | 333.23 Billion KRW | 17.06% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 7.59 Billion KRW | 0.0% |
| 2009 Q3 | 5.09 Billion KRW | 23.1% |
| 2009 Q2 | 4.13 Billion KRW | 9.75% |
| 2009 Q1 | 3.77 Billion KRW | 0.0% |
| 2009 FY | 284.68 Billion KRW | 29.73% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 Q3 | 3.32 Billion KRW | -15.88% |
| 2008 Q2 | 3.94 Billion KRW | 18.05% |
| 2008 Q1 | 3.34 Billion KRW | 0.0% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 219.43 Billion KRW | -16.91% |
| 2007 Q1 | 2.13 Billion KRW | 0.0% |
| 2007 FY | 264.09 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 3.9 Billion KRW | 82.79% |
| 2007 Q3 | 3.6 Billion KRW | -7.82% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ORIENT BIO Inc. | 9.58 Billion KRW | -6197.552% |
| Green Cross Holdings Corporation | 458.68 Billion KRW | -31.589% |
| Pharmicell Co., Ltd. | 14.95 Billion KRW | -3935.942% |
| Green Cross Corporation | 458.68 Billion KRW | -31.589% |
| GeneOne Life Science, Inc. | -14.98 Billion KRW | 4128.099% |
| Celltrion, Inc. | 1010.9 Billion KRW | 40.293% |
| Samsung Biologics Co.,Ltd. | 1802.76 Billion KRW | 66.519% |
| SK bioscience Co.,Ltd. | 142.24 Billion KRW | -324.333% |
| SK Biopharmaceuticals Co., Ltd. | 308.37 Billion KRW | -95.73% |
| Prestige BioPharma Limited | 689.07 Million KRW | -87493.187% |